Applicant's U.S. patent application Ser. No. 611,836, now U.S. Pat. No. 4,607,639, describes a method for controlling the function of a bladder, including identification of selected nerve bundles controlling the separate functions of the bladder and its external sphincter and the application of pulse trains to one or more electrodes positioned on the nerve bundles to control the functions of the bladder and external sphincter. The methods taught herein utilize similar method steps for modulating symptoms resulting from a loss of coordination between the normally synchronized functions of a bladder and bowel and their associated sphincters. The methods are also used for treating incontinence by increasing sphincter tonus. The use of similar method steps for controlling evacuation of the bowel is also disclosed.

Patent
   4739764
Priority
May 18 1984
Filed
Apr 22 1986
Issued
Apr 26 1988
Expiry
Apr 26 2005
Assg.orig
Entity
Large
216
3
all paid
35. A method for simultaneously controlling the coordinated and synchronized functions of a bowel and associated sphincter in an anatomical system of a selected human, said system including S2, S3 and S4 sacral segments of a spinal cord and a sacral nerve originating at each of said sacral segments and each of said sacral nerves including a dorsal root and a ventral root in a sacral canal, said sacral nerves forming a pelvic nerve when they leave the sacral canal connected to said bladder to control contractions of a detrusor muscle thereof, a superior somatic nerve and a pudendal nerve including an inferior somatic nerve connected to muscles controlling the external sphincter of said bladder, and an anal branch connected to an urethral said method comprising the steps of
identifying the anatomical location and functional characteristics of those nerve bundles controlling the separate functions of said bowel and sphincter,
separating motor, sensory and autonomic and somatic nerve fibers controlling the separate functions of the bowel and associated sphincter from other nerve fibers,
positioning electrode means on selected ones of said nerve bundles for electrically stimulating such fibers while simultaneously isolating adjacent nerve fibers therefrom, and
applying coordinated and synchronized pulse trains sequentially or simultaneously to said electrode means to simultaneously and/or separately control the functions of said bowel and sphincter.
1. A method for modulating symptoms resulting from a loss of coordination between the normally synchronized functions of organs and for treatment of incontinence by increasing sphincter tonus either by direct stimulation of a sphincter muscle or by modulating reflex control mechanisms so that more effective sphincter tonus results, said organs including a bladder, a rectum and associated sphincters, in an anatomical system of a selected human, said system including S2 and S3 and S4 sacral segments of a spinal cord and a sacral nerve originating at each of said sacral segments, said sacral nerves forming a pelvic nerve when they leave the sacral canal, connected to said bladder to control contractions of a detrusor muscle thereof, and somatic components that subdivide into (1) a superior somatic nerve and (2) a pudendal nerve, including (a) an inferior somatic nerve connected to muscles controlling the external sphincter of said bladder, (b) an anal branch connected to an anal sphincter for said rectum, and (c) a dorsal nerve connected to a penis, the nerve bundle connected to said sphincters being controllable at a lower level of electrical stimulation than that required to control the functions of said bladder and rectum,
said method comprising the steps of
identifying the anatomical location and functional characteristics of selected nerve bundles controlling the separate function of at least one organ of said organs,
positioning electrode means on said nerve bundles for electrically stimulating said nerve bundles while simultaneously isolating adjacent nerve bundles therefrom, and
applying pulse trains sequentially to said electrode means to separately control the function of at least said one organ.
2. The method of claim 1 positioning step comprises positioning at least two separate electrodes each on a separate nerve bundle and said applying step comprises applying coordinated and synchronized pulse trains sequentially or simultaneously to said electrode means to simultaneously and/or separately control the function of at least one of said organs.
3. The method of claim 2 wherein said positioning step comprises positioning a separate electrode on each of at least two separate nerve bundles, selected from the sacral nerve nerves originating at said sacral segments, said pudendal nerve, said superior somatic nerve, said inferior somatic nerve and said anal branch, for modulating symptoms resulting from a loss of coordination between the normally synchronized functions of said organs.
4. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve and said pudendal nerve.
5. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve and said superior somatic nerve.
6. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve and said inferior somatic nerve.
7. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve and said anal branch.
8. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve, said pudendal nerve and said superior somatic nerve.
9. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve, said superior somatic nerve, and said inferior somatic nerve.
10. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 sacral nerve, said superior somatic nerve, and said anal branch.
11. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve and said pudendal nerve.
12. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve and said superior somatic nerve.
13. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve and said inferior somatic nerve.
14. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve and said anal branch.
15. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve, said pudendal nerve and said superior somatic nerve.
16. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve, said superior somatic nerve and said inferior somatic nerve.
17. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S3 sacral nerve, said superior somatic nerve and said anal branch.
18. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves, and said pudendal nerve.
19. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves and said superior somatic nerve.
20. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves and said inferior somatic nerve.
21. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves and said anal branch.
22. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves, said pudendal nerve, and said superior somatic nerve.
23. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves and said superior somatic nerve.
24. The method of claim 3 wherein said positioning step comprises positioning an electrode on each of said S2 and S3 sacral nerves, said superior somatic nerve and said inferior somatic nerve.
25. The method of claim 3 wherein said positioning step comprises positioning said electrodes unilaterally on said separate nerve bundles.
26. The method of claim 3 wherein said positioning step comprises positioning said electrodes bilaterally on said separate nerve bundles.
27. The method of claim 1 wherein said positioning step comprises positioning at least one separate electrode on at least one nerve bundle selected from said pudendal nerve, said superior somatic nerve, said inferior somatic nerve and said anal branch and said applying step comprises treating incontinence by increasing sphincter tonus either by direct stimulation of the sphincter muscle or by modulating reflex control mechanisms so that more effective sphincter tone results.
28. The method of claim 27 wherein said positioning step comprises positioning an electrode on said pudendal nerve.
29. The method of claim 27 wherein said positioning step comprises positioning an electrode on said superior somatic nerve.
30. The method of claim 27 wherein said positioning step comprises positioning an electrode on said inferior somatic nerve.
31. The method of claim 27 wherein said positioning step comprises positioning an electrode on said anal branch.
32. The method of claim 27 wherein said positioning step comprises positioning an electrode on each of said pudendal nerve and said superior somatic nerve.
33. The method of claim 27 wherein said positioning step comprises positioning an electrode on each of said superior somatic nerve and said inferior somatic nerve.
34. The method of claim 27 wherein said positioning step comprises positioning an electrode on each of said superior somatic nerve and said anal branch.

This invention was made with government support under Grant Nos. NS 2307 and R01 18029-04 awarded by the Department of Health and Human Services. The Government has certain rights in this invention.

This application is a continuation in part of U.S. patent application Ser. No. 611,836, filed on May 18, 1984 for "Method and System for Controlling Bladder Evacuation," now U.S. Pat. No. 4,607,639.

This invention relates generally to a method for regulating and treating bodily functions and, more particularly, to the utilization of one or more electrodes on selected nerve bundles and the application of pulse trains to the electrode(s) to regulate or treat such functions.

Various medical patients exhibit involuntary control over their bladder and/or bowel. Although vesicostomy or an artificial sphincter implanted around the urethra are commonly used to provide partial control over the evacuation function of the bladder and to control continence, these solutions have drawbacks well known to those skilled in the medical profession and related arts. Other patients who achieve a modicum of control over their bladder functions are equally in need of a system to rehabilitate their nerve and muscle dysfunctions. Similar problems arise in respect to involuntary bowel control.

The physiology of the bladder and bowel is closely linked to the urethral muscle physiology of the pelvic floor (levator ani muscle) and its related urethral and anal sphincters. For the bladder to store urine and for the bowel to serve as a reservoir for feces, two opposite, but complementary, behaviors are found. In particular, the bladder and rectum must relax and the urethral and anal sphincters must remain contracted. The reverse is true during evacuation of either urine or feces, i.e., the urethral or anal sphincter will relax, along with the pelvic floor, and subsequently the bladder and rectum will contract.

The sequence will reverse once voiding and defecation is completed, i.e., the sphincters and pelvic floor muscles will revert to their tonic closure states and the bladder and rectum will revert to their storage states. This behavior has been demonstrated by simultaneous manometric (or EMG/pressure) recordings of this bladder/rectum, urethral/anal behavior during filling and emptying of the bladder. This sequence of events is well-established and is accepted universally.

Applicants U.S. patent application Ser. No. 611,836, now U.S. Pat. No. 4,607,639, describes methods for controlling the function of the bladder, with such methods also being adapted to "effect control of other organs, such as the bowel, colon and associated sphincters, (e.g., anus) and cuffs." In reference to FIG. 4, such application also states that the described procedure "will normally provide means for selectively eliminating or supressing spasting detrusor activity, spastic urethal and pelvic floor activity and spastic anal sphincter." This application describes specific methods for stimulating pelvic floor muscles to modulate symptoms resulting from a loss of coordination between the normally synchronized functions of the bladder and bowel and for treating incontinence by increasing sphincter tonus. Also, a method for controlling bowel evacuation is disclosed.

This invention extends the teachings of parent U.S. patent application Ser. No. 611,836 now U.S. Pat. No. 4,607,639 by disclosing twenty-one specific methods for modulating the symptoms resulting from a loss of coordination between normally synchronized functions of visceral organs and seven methods for treating incontinence by increasing sphincter tonus. The term "controlling" as used herein not only includes the selective control of the bladder's and/or bowel's evacuation and related sphincter functions on a continuous basis, but further includes isolated or periodic control of such functions for diagnostic or rehabilitation purposes, e.g., neuromodulation of muscular behavior to rehabilitate muscular dysfunction in the pelvic floor without stimulating the pelvic nerve controlling the bladder's detrusor muscle. The term "organn" as used herein broadly means an independent part of the human body that performs a special function or functions, including visceral organs such as the bladder, bowel and colon and associated sphincters and cuffs.

In one aspect, the method of this invention comprises the identification of the anatomical location and functional characteristics of selected nerve bundles controlling the separate function of at least one organ, including a person's bladder, rectum and/or associated sphincters. Electrode means is then positioned on such nerve bundles for electrically stimulating the nerve bundles while simultaneously isolating adjacent nerve bundles therefrom. Pulse trains are sequentially applied to the electrode means to separately control the function of the one organ or a number of organs simultaneously. In the preferred embodiments of this invention, the positioning step comprises attaching two or more electrodes in twenty-one different combinations on selected nerve bundles for modulation purposes and in seven locations on selected nerve bundles for increasing sphincter tonus. Each method disclosed can be carried forth either bilaterally or unilaterally, depending on a particular patient's needs.

In another aspect of this invention, the method taught in applicant's parent U.S. patent application Ser. No. 611,836 now U.S. Pat. No. 4,607,639 is utilized to control the coordinated and synchronized function of a bowel and associated sphincter.

Other advantages and objects of this invention will become apparent from the following description and accompanying drawings wherein:

FIG. 1 schematically illustrates the pelvic plexus region in a human, including the nervous system for controlling bladder evacuation and related functions, and further illustrates a first operative procedure for controlling such functions;

FIG. 2 schematically illustrates a stimulation-response curve of bladder contraction in response to stimulation of the S2, S3 and S4 sacral nerves;

FIGS. 3 and 4 are views similar to FIG. 1, but illustrate additional operative procedures for controlling bladder evacuation and related functions;

FIG. 5 schematically illustrates the percutaneous implantation of an electrode adjacent to the S3 sacral nerve through the dorsum for the purpose of selectively stimulating such nerve;

FIGS. 6-11 are views similar to FIG. 1, but illustrate additional operative procedures for controlling bladder evacuation and related functions;

FIG. 12 illustrates a micturition control system adapted for use in conjunction with an operative procedure for controlling bladder and/or bowel evacuation and related functions;

FIG. 13 schematically illustrates a typical electronic circuit for use in an implantable receiver of the FIG. 12 micturition control system;

FIG. 14 diagramatically illustrates electronic signals and their time relationship for the FIG. 12 micturition control system;

FIG. 15 illustrates an electrode arrangement including pairs of electrodes attached to separate nerve fibers and adapted for use with the FIG. 12 control system;

FIG. 16 is a view similar to FIG. 15, but illustrates a multiplicity of active electrode contacts on single electrodes;

FIG. 17 diagramatically illustrates electrical impulses in their timed relationship for the electrode arrangements illustrated in FIGS. 15 and 16; and

FIG. 18 is a view similar to FIG. 1, but illustrates the positioning of electrodes on various nerve bundles to effect desired results, as reflected in Charts I and II, set forth hereinafter.

As described in U.S. patent application Ser. No. 611,836, now U.S. Pat. No. 4,607,639, FIG. 1 schematically illustrates the pelvic plexus region of a human, including the nervous system for controlling bladder evacuation and related functions. The nervous system includes a somatic nerve system of fibers (or nerve bundles) S and an autonomic nerve system of nerve bundles A, finding their immediate origin at sacral segments S2, S3 and S4 of the spinal cord and sacrum, i.e., the triangular bone positioned below the lumbar vertebrae and comprising five fused sacral vertebrae that are wedge dorsally between the two hip bones. As illustrated in FIG. 2, the main nerve supply to the detrusor muscle of a bladder B emanates primarily from sacral segment S3, a lesser amount from sacral segment S2, and a still lesser amount from sacral segment S4, i.e., "response" refers to bladder response.

The application further teaches a method for controlling the evacuation of bladder B by first identifying the anatomical location of at least one nerve or component thereof that controls at least one function of the bladder, e.g., continence and/or contraction of the bladder. An electrode is then positioned, either surgically or percutaneously, at least in close proximity to the nerve and selectively energized to stimulate the nerve. Although the operative procedures, methods and systems described in the application were noted as being "particularly applicable to controlling bladder and related functions," it was further noted that "such procedures, methods and systems may also concurrently effect control of other organs, such as the bowel, colon and associated sphincters, (e.g., anus) and cuffs" and may be used to "normally provide means for eliminating or supressing spastic detrusor activity, spastic urethal and pelvic floor activity and spastic anal sphincter." Either permanent surgical implantation or temporary percutaneous implantation for nerve stimulation purposes was also taught.

As further illustrated in FIG. 1, the main nerve supply emanating from each sacral segment S2, S3 and S4 comprises two components or roots, namely, a dorsal root D and a ventral root V. The dorsal root is primarily sensory to transmit sensation to the spinal cord whereas the ventral root is primarily motor to transmit motor impulses from the spinal cord to bladder B and associated sphincter. Although illustrated as being separated, the dorsal and ventral roots for each nerve are, in fact, normally joined together and their fibers or bundles mixed to progress as a single trunk.

Bundles of the nerve trunk are divided into somatic nerve bundles S that connect to voluntary muscles and autonomic nerve bundles A that connect to visceral organs, such as bladder B. Dorsal root D can be separated from ventral root V since only stimulation of the motor nerve bundles of a particular ventral root are contemplated in many procedures. In this manner, the motor nerve bundles can be stimulated without inducing pain and without generating impulses along the sensory passageway.

Somatic nerves S and autonomic nerves A can also be separated from each other. For example, in a particular procedure wherein it is desireable to only drive muscles controlled by the somatic nerve, the somatic nerve can be solely stimulated. Should it prove desirable to control the muscles of only a visceral organ, such as the detrusor muscle of bladder B, the autonomic nerve bundles could be stimulated. Stimulation of the entire nerve trunk would function to stimulate each of the dorsal, ventral, somatic and autonomic nerve bundles.

FIGS. 1 and 3-11 illustrate various combinations of operative procedures for effecting the desired neurostimulation for specific case studies (male or female). For example, a quadriplegic who has suffered a neck injury and damage to his spinal cord will normally require an operative procedure wherein control of bladder B and external sphincter E are of utmost importance. In addition, the quadriplegic will suffer uncontrolled bowel evacuation, for example, which can be concurrently controlled when bladder control is effected by such operative procedure. In addition, it may prove desirable to modulate other voiding dysfunctions that may occur as a result of one or more of a multitude of other neurological reasons.

Thus, it is emphasized in applicants' parent application that the specific operative procedures therein described can be combined with one or more of the other procedures described therein, as dictated by pre-operative evaluation of responses to stimulation recorded urodynamically. For example, when a particular procedure (e.g., electrode implant, nerve separation, sectioning, etc.) is described as being performed bilaterally, clinical testing may indicate that in certain other patients, a unilateral procedure is necessary (and vice versa). Likewise, the specific steps or procedures utilized in one operative procedure (FIGS. 1 and 3-11) may be utilized in combination with one or more steps utilized in other operative procedures, as will be appreciated by those skilled in the arts relating hereto.

As further taught in applicants' parent application, although the operative procedures therein described are primarily useful and applicable to control of bladder functions, such procedures are concurrently applicable to the control of other organs, including the bowel and colon, associated sphincters (e.g., anus) and cuffs and to the elimination or supression of spastic detrusor activity, spastic urethal and pelvic floor activity and spastic anal sphincter. In all of the described operative procedures, it is assumed that pre-operative evaluation of response to stimulation has been recorded urodynamically to precisely locate the nerves requiring separation, neurostimulation and/or isolation, such as by sectioning.

Further details and description of the FIGS. 1 and 3-11 operative procedures, as well as those pertaining to the control system shown in FIGS. 12-17, are incorporated herein by specific reference to applicants' U.S. patent application Ser. No. 611,836, now U.S. Pat. No. 4,607,639.

The following description supplements that found in applicants' parent application. The physiology of the bladder and bowel is closely linked to the urethral muscle physiology of the pelvic floor and its related urethral and anal sphincters. The sequences for storage (continence) and evacuation suggest that the somatic muscles of the pelvic floor are principally responsible for both continence and evacuation. During the storage phase, the visceral organs, i.e., bowel/bladder, are either released from the reflex inhibition or are directly facilitated into contracting, or both. It has been determined that neural control of the pelvic muscles largely determines the state of activity of the pelvic viscera (bowel, bladder, and possibly erection). A simple example is the "hold" reflex used to suppress a strong urge to void or defecate at inconvenient times.

If the neural regulation of bladder and bowel activity is directly tied to that of the pelvic muscles in the normal, then it is most certainly tied to it in the abnormal. Just as the hold reflex is used to suppress an inconvenient urge to empty either the bladder or bowel, an electrically induced contraction of the pelvic sphincters can be used to suppress an overly active bladder or bowel.

There is a broad spectrum of patients who experience a multitude of symptoms resulting from dysfunctional behavior of the bladder, bowel, urethra, anal and pelvic floor muscle systems. Not uncommonly, the muscle dysfunction cannot be ascribed to any disease. The muscle dysfunction can, however, be very similar to that found for other neural disorders (e.g., meningomyelocele, hydrocephalus, spinal injury, multiple sclerosis, stroke, etc.). The visceral dysfunction can be demonstrated especially in the case of the bladder--to be associated with pelvic muscle dysfunction, with the behavior of the bladder being a direct result of excessive inhibition (e.g., inability to void completely because of an inability to relax the urinary sphincter completely), or excessive triggering of bladder contractions (i.e., a precipitate urge to void one's bladder) because of a breakdown in the efficiency of reflex coordination between the bladder and pelvic muscles. A similar analogy can be made for problems affecting the bowel (as well as erection). Correction of the pelvic muscle dysfunction can thus serve to correct the visceral muscle dysfunction. Other effects described by patients have included the reduction of severe neck spasm, back spasm and leg cramps.

Visceral muscle dysfunctions which can be considered a result of overfacilitated activity include the spastic colon, interstitial cystitis, detrusor instability, cardiovascular problems such as migraine headache or palpatations, and bladder retention syndromes. Somatic muscle dysfunctions directly resulting from poor neural regulation and overfacilitated behavior include: pelvic pain syndromes, frequency syndromes (pelvic floor and/or urethral instability), incontinency due to poor relaxation or instability of the sphincters (either bowel or bladder), and incontinence following prostatectomy.

Each of the above has been shown to respond to stimulation of the somatic muscles of the pelvic floor (primarily levator ani muscle I in FIG. 18). Neurostimulation of the pelvic muscles has a stabilizing effect on their neuro-regulatory mechanisms. Behavorial stabilization of pelvic muscles then affects the neuro control of the viscera.

Because of the similarity in nervous control between the bowel and bladder, the following bowel problems may also be treatable by a sacral or pudendal nerve electrode implant, namely, "spastic colon", and fecal incontinence either from spasticity or incompetence of the anal sphincter, and infrequent or too frequent bowel movements.

A spinoff benefit that has been noted is the treatment of foot drop. It appears that the planter flexion of the distal half of the foot and toes gives added stability to the gait. It has long been believed that foot drop was the result of a weakness in the muscles controlled by the perineal nerve. Stimulation of this nerve has been used to lift the foot using the foot dorsiflexors, but with limited success. Foot drop has been shown to improve by stimulation of sacral S3 nerve root N3 because of a better push the foot has as a result of planter flexion.

FIG. 18 illustrates letters depicting various components of the pelvic plexus region of a human that are common to those described in applicants' parent application. The following listing includes newly discussed components, shown in FIG. 18, as well as the common ones:

A: Autonomic nerve system.

B: Bladder.

C1-C6: Electrodes, shown as cuff electrodes for illustration purposes (other types could be used).

D: Dorsal root of nerve (sensory).

E: External sphincter of bladder B.

F: Foramen electrode.

I: Internal sphincter or levator ani muscle (pelvis floor, i.e., the composite muscular structure that constitutes the outlet of the boney pelvis and primarily consisting of the levator ani muscle).

J: Dorsal nerve of the penis.

L: Anal branch of pudendal nerve T.

N2, N3: Sacral nerves originating at sacral segments S2 and S3, respectively.

P: Pelvic nerves connected between the sacral nerves and the detrusor muscle of bladder B.

R: Anal sphincter (sphincter ani).

SI : Inferior somatic nerve.

SS : Superior somatic nerve.

T: Pudendal nerve.

U: Urethra.

V: Ventral root of nerve (motor).

Methods herein disclosed (Chart I) can be used to either modulate symptoms resulting from a loss of coordination between the normally synchronized functions of organs, including bladder B, rectum R and associated bladder sphincters E and I and the anal sphincter for rectum R, or to treat incontinence by increasing sphincter tonus (Chart II). As described in the parent application, sacral nerves N2 and N3 originate at sacral segments S2 and S3, respectively, and form pelvic nerve P that controls contraction of a detrusor muscle surrounding bladder B. The sacral nerves also form somatic components that subdivide into: (1) superior somatic nerve SS ; and (2) pudendal nerve T that includes (a) inferior somatic nerve SI connected to muscles controlling external sphincter E of bladder B, (b) anal branch L connected to the anal sphincter for rectum R, and (c) dorsal nerve J connected to the penis. The nerve bundles connected to the various sphincters are controllable at a lower level of electrical stimulation than that required to control the muscles for the bladder and rectum proper.

FIG. 18 illustrates six cuff electrodes C1-C6 adapted to be positioned on selected nerve bundles (while simultaneously isolating adjacent nerve bundles) either individually or in combination with at least one other electrode for stimulation purposes. As described in the parent application, such positioning step occurs after identifying the anatomical location and functional characteristics of the selected nerve bundle or bundles. Pulse trains are then applied sequentially to the electrode or electrodes to control the function of the organ.

Individually, electrodes C1--C6 modulate or control the function(s) of the following organs:

C1: Bladder sphincter E, anal sphincter R and the detrusor muscle for bladder B.

C2: The detrusor muscle for bladder B and both bladder and anal sphincters E and R.

C3: Both bladder and anal sphincters E and R.

C4: Internal sphincter I (pelvic floor).

C5: Bladder sphincter E.

C6: Anal sphincter R.

The following chart indicates twenty-one different combinations of electrode placement (unilaterally or bilaterally) for modulating the above-discussed symptoms resulting from a loss of coordination between a person's organs, including bladder B rectum R and associated sphincters:

__________________________________________________________________________
C4 C5
C1 C2 C3 Superior
Inferior
C6
Organ(s)
Sacral
Sacral
Pudendal
Somatic
Somatic
Anal Branch
Affected
Nerve N2
Nerve N3
Nerve T
Nerves S S
Nerve S I
L
__________________________________________________________________________
(1) B, E, R
X X
(2) B, E, R, I
X X
(3) B, E, R
X X
(4) B, E, R
X X
(5) B, E, R, I
X X X
(6) B, E, R, I
X X X
(7) B, E, R, I
X X X
(8) B, E, R X X
(9) B, E, R, I
X X
(10) B, E, R X X
(11) B, E, R X X
(12) B, E, R, I
X X X
(13) B, E, R, I
X X X
(14) B, E, R X X X
(15) B, E, R
X X X
(16) B, E, R, I
X X X
(17) B, E, R
X X X
(18) B, E, R
X X X
(19) B, E, R, I
X X X X
(20) B, E, R, I
X X X
(21) B, E, R, I
X X X X
__________________________________________________________________________

The following second chart indicates electrode placement (unilaterally or bilaterally) for treatment of incontinence by increasing sphincter tonus either by direct stimulation of a sphincter muscle or by modulating reflex control mechanisms so that more effective sphincter tonus results:

______________________________________
C4 C5
C3 Superior Inferior
C6
Organ(s) Pudendal Somatic Somatic
Anal
Affected Nerve T Nerves S S
Nerve S I
Branch L
______________________________________
(1) E, R X
(2) I X
(Pelvic Floor)
(3) E X
(4) R X
(5) E, R, I
X X
(6) I, E X X
(7) I, R X X
______________________________________

The term "reflex control mechanisms" means those nerve bundles that control interrelated activity between bladder B and pelvic floor musculature (primarily levator ani muscle I) as they can reflexively influence each other by either inhibition or facilitation.

It should be noted in the charts that various electrode combinations may affect the identical organs, but to different degrees of intensity. For example, although electrode combinations (1) and (8) in Chart I each affect bladder B, bladder sphincter E and anal sphincter R, in combination (8) the bladder will be relatively more responsive since the main pelvic nerve supply P emanates primarily from sacral segment S3 and to a lesser amount from sacral segment S2.

The site or sites chosen for implantation of an electrode is determined by careful evaluation of a patient's problems. Such evaluations consist of symptom analysis, physical deficits or variations in muscle behavior of the lower extremities and pelvic muscles, or loss of sensation, the results of urodynamic testing and the results of test stimulation of the various sacral nerves. A temporary electrode is normally inserted percutaneously into one or more of the sacral foramena and specific nerve roots test stimulated for a response. When a desired response is obtained, a temporary electrode can be "floated" (e.g., Foramen electrode F in FIG. 18) in the vicinity of the nerve or nerves. This procedure allows the patient to have a three to five day trial of stimulation to evaluate the therapeutic benefits of stimulation.

Based on the response obtained with the test stimulation, the patient can be further evaluated for the response to be obtained by percutaneously implanting an electrode on one or more of the selected nerve bundles or an electrode can be permanently implanted, either via sacral laminectomy and placement of an electrode directly on a specific sacral nerve or by placing an electrode on the sacral foramen without performing a laminectomy. Therapeutic benefits are thus obtained by stimulation of specific pelvic muscles.

Applicants have further determined that the nerves controlling functions of the bladder also have a similar influence over the bowel. The same pathways and principles of stimulation described for control of the bladder also apply in respect to control of the bowel. Thus, the operative procedures described in applicants' parent application are equally applicable to bowel control.

Schmidt, Richard, Tanagho, Emil A., Gleason, Curtis A., Lue, Tom

Patent Priority Assignee Title
10004896, Jan 21 2015 BLUEWIND MEDICAL LTD. Anchors and implant devices
10105540, Nov 09 2015 BLUEWIND MEDICAL LTD Optimization of application of current
10124178, Nov 23 2016 BLUEWIND MEDICAL LTD Implant and delivery tool therefor
10159838, Sep 08 2004 TC1 LLC Methods for stimulating a dorsal root ganglion
10173060, Jun 02 2014 CALA HEALTH, INC Methods for peripheral nerve stimulation
10179238, Jun 02 2014 CALA HEALTH, INC Systems for peripheral nerve stimulation
10232180, Sep 08 2004 TC1 LLC Selective stimulation to modulate the sympathetic nervous system
10238863, Dec 06 2012 BLUEWIND MEDICAL LTD. Delivery of implantable neurostimulators
10250495, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
10292802, Jan 11 2010 ForConti Medical Ltd. Device and method for controlling fecal incontinence
10293168, Jun 10 2005 Medtronic Urinary Solutions, Inc. Systems and methods for clinician control of stimulation systems
10322287, Sep 07 2006 Medtronic Urinary Solutions, Inc. Systems and methods for patient control of stimulation systems
10358629, Mar 08 2006 KWALATA TRADING LIMITED Regulating stem cells
10369366, Jun 10 2015 BLUEWIND MEDICAL LTD. Implantable electrostimulator for improving blood flow
10376694, Oct 09 2008 Method and apparatus for stimulating the vascular system
10434320, Jun 10 2005 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
10449374, Nov 12 2015 BLUEWIND MEDICAL LTD Inhibition of implant migration
10523561, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
10549093, Jun 02 2014 CALA HEALTH, INC Method for peripheral nerve stimulation
10561839, Jun 02 2014 CALA HEALTH, INC Systems for peripheral nerve stimulation
10576278, Feb 21 2012 System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
10603489, Oct 09 2008 Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
10625074, Jan 21 2013 CALA HEALTH, INC Devices and methods for controlling tremor
10653888, Jan 26 2012 BLUEWIND MEDICAL LTD Wireless neurostimulators
10744331, Nov 23 2016 BLUEWIND MEDICAL LTD. Implant and delivery tool therefor
10765856, Jun 10 2015 CALA HEALTH, INC Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units
10814130, Jul 08 2016 CALA HEALTH, INC Dry electrodes for transcutaneous nerve stimulation
10850090, Jan 21 2013 CALA HEALTH, INC Devices and methods for controlling tremor
10905879, Jun 02 2014 CALA HEALTH, INC Methods for peripheral nerve stimulation
10911350, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
10960207, Jun 02 2014 CALA HEALTH, INC Systems for peripheral nerve stimulation
11045649, Feb 19 2016 Medtronic, Inc.; Medtronic, Inc Incontinence therapy
11116975, Nov 09 2015 BLUEWIND MEDICAL LTD. Optimization of application of current
11213685, Jun 13 2017 BLUEWIND MEDICAL LTD. Antenna configuration
11278719, Dec 06 2012 BLUEWIND MEDICAL LTD. Delivery of implantable neurostimulators
11318310, Oct 26 2015 Nevro Corp Neuromodulation for altering autonomic functions, and associated systems and methods
11331480, Apr 03 2017 CALA HEALTH, INC Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
11344722, Jan 21 2016 CALA HEALTH, INC Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
11400299, Sep 14 2021 Rainbow Medical Ltd Flexible antenna for stimulator
11413451, May 10 2010 TC1 LLC Methods, systems and devices for reducing migration
11418437, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
11439833, Nov 23 2016 BLUEWIND MEDICAL LTD. Implant-delivery tool
11464966, Dec 06 2012 BLUEWIND MEDICAL LTD. Delivery of implantable neurostimulators
11517749, Oct 09 2008 Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
11590352, Jan 29 2019 Nevro Corp Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
11596785, Sep 23 2015 CALA HEALTH, INC Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
11612747, Nov 09 2015 BLUEWIND MEDICAL LTD. Optimization of application of current
11648410, Jan 26 2012 BLUEWIND MEDICAL LTD. Wireless neurostimulators
11838205, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
11857778, Jan 17 2018 CALA HEALTH, INC Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
11890468, Oct 03 2019 CALA HEALTH, INC Neurostimulation systems with event pattern detection and classification
11890472, Oct 27 2008 TC1 LLC Selective stimulation systems and signal parameters for medical conditions
5193539, Dec 18 1991 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH, THE Implantable microstimulator
5193540, Dec 18 1991 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH Structure and method of manufacture of an implantable microstimulator
5199430, Mar 11 1991 Case Western Reserve University Micturitional assist device
5324316, Dec 18 1991 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH, THE Implantable microstimulator
5484445, Oct 12 1993 Medtronic, Inc Sacral lead anchoring system
5562717, May 23 1992 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuromuscular disorders
6002964, Jul 15 1998 ADVANCED NEUROMODULATION SYSTEMS, INC D B A ST JUDE MEDICAL NEUROMODULATION DIVISION Epidural nerve root stimulation
6104957, Aug 21 1998 ADVANCED NEUROMODULATION SYSTEMS, INC D B A ST JUDE MEDICAL NEUROMODULATION DIVISION Epidural nerve root stimulation with lead placement method
6354991, Oct 06 1998 AMS Research Corporation Incontinence treatment device
6516227, Jul 27 1999 Boston Scientific Neuromodulation Corporation Rechargeable spinal cord stimulator system
6652449, Oct 06 1998 ASTORA WOMEN S HEALTH, LLC Control of urge incontinence
6684105, Aug 31 2001 Medtronic, Inc Treatment of disorders by unidirectional nerve stimulation
6712772, Nov 29 2001 ASTORA WOMEN S HEALTH, LLC Low power consumption implantable pressure sensor
6735474, Jul 06 1998 Boston Scientific Neuromodulation Corporation Implantable stimulator system and method for treatment of incontinence and pain
6847849, Nov 15 2000 MAMO, LAURA Minimally invasive apparatus for implanting a sacral stimulation lead
6862480, Nov 29 2001 ASTORA WOMEN S HEALTH, LLC Pelvic disorder treatment device
6871099, Aug 18 2000 Boston Scientific Neuromodulation Corporation Fully implantable microstimulator for spinal cord stimulation as a therapy for chronic pain
6892098, Apr 26 2001 BIO CONTROL MEDICAL B C M LTD Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders
6895280, Jul 27 1999 Boston Scientific Neuromodulation Corporation Rechargeable spinal cord stimulator system
6896651, Oct 06 1998 Medtronic, Inc Mechanical and electrical sensing for incontinence treatment
6907293, Mar 30 2001 Case Western Reserve University Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
6907295, Aug 31 2001 Medtronic, Inc Electrode assembly for nerve control
6915165, Jun 28 2001 ABDOMNICA AG; ABDOMICA AG Intestine dysfunction treatment apparatus
6928320, May 17 2001 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
6941171, Jul 06 1998 Boston Scientific Neuromodulation Corporation Implantable stimulator methods for treatment of incontinence and pain
6971393, Nov 15 2000 MAMO, LAURA Minimally invasive method for implanting a sacral stimulation lead
6999819, Aug 31 2001 MAMO, LAURA Implantable medical electrical stimulation lead fixation method and apparatus
7047078, Mar 30 2001 Case Western Reserve University Methods for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
7054689, Aug 18 2000 Boston Scientific Neuromodulation Corporation Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction
7079882, Jan 22 2000 Medtronic, Inc Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions
7251529, May 29 2002 Oklahoma Foundation for Digestive Research Spinal cord stimulation as treatment for functional bowel disorders
7276057, Sep 06 2002 Medtronic, Inc Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
7321793, Jun 13 2003 Medtronic, Inc Vagal stimulation for atrial fibrillation therapy
7324853, Aug 31 2001 Medtronic, Inc Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders
7328068, Nov 26 2003 Medtronic, Inc Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
7328069, Sep 06 2002 Medtronic, Inc Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
7330764, Aug 31 2001 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
7337005, Sep 08 2004 TC1 LLC Methods for stimulating a nerve root ganglion
7337006, Sep 08 2004 TC1 LLC Methods and systems for modulating neural tissue
7343202, Feb 12 2004 MEDTRONIC URINARY SOLUTIONS, INC Method for affecting urinary function with electrode implantation in adipose tissue
7346398, Aug 31 2001 Medtronic, Inc Electrode assembly for nerve control
7369894, Sep 06 2002 Medtronic, Inc Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
7387603, Oct 06 1998 ASTORA WOMEN S HEALTH, LLC Incontinence treatment device
7400926, Jun 28 2001 Urologica AG Intestine dysfunction treatment apparatus
7427280, Sep 06 2002 Medtronic, Inc Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
7433734, May 17 2001 Medtronic, Inc. Apparatus and method for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
7447546, Sep 08 2004 TC1 LLC Methods of neurostimulating targeted neural tissue
7450993, Sep 08 2004 TC1 LLC Methods for selective stimulation of a ganglion
7502651, Sep 08 2004 TC1 LLC Methods for stimulating a dorsal root ganglion
7519429, Jan 31 2001 Electronic stimulator implant
7545740, Apr 07 2006 ORCKIT IP, LLC; ORCKIT CORPORATION Two-way link aggregation
7551599, Mar 29 2004 SMART PATH CONNECTIONS LLC Layer-3 network routing with RPR layer-2 visibility
7561922, Dec 22 2004 Medtronic, Inc Construction of electrode assembly for nerve control
7565198, Feb 12 2004 MEDTRONIC URINARY SOLUTIONS, INC Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence
7571000, Sep 12 2003 Case Western Reserve University Apparatus for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
7580753, Sep 08 2004 TC1 LLC Method and system for stimulating a dorsal root ganglion
7582053, Oct 06 1998 Medtronic, Inc Control of urge incontinence
7613516, Nov 29 2001 Medtronic, Inc Pelvic disorder treatment device
7623925, Mar 30 2001 Case Western Reserve University Methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
7627384, Nov 15 2004 Medtronic, Inc Techniques for nerve stimulation
7634317, Aug 31 2001 Medtronic, Inc Techniques for applying, calibrating, and controlling nerve fiber stimulation
7643876, Aug 31 2006 Cardiac Pacemakers, Inc. System and method to reduce device therapy pain
7729772, Jan 07 2005 UROPLASTY, LLC Implantable neuromodulation system and method
7734355, Aug 31 2001 Medtronic, Inc Treatment of disorders by unidirectional nerve stimulation
7761167, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Systems and methods for clinician control of stimulation systems
7769460, Jul 29 2005 Medtronic, Inc Transmembrane sensing device for sensing bladder condition
7778703, Aug 31 2001 Medtronic, Inc Selective nerve fiber stimulation for treating heart conditions
7778711, Aug 31 2001 Medtronic, Inc Reduction of heart rate variability by parasympathetic stimulation
7813809, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
7844346, May 23 2002 Medtronic, Inc Electrode assembly for nerve control
7885709, Sep 23 2004 Medtronic, Inc Nerve stimulation for treating disorders
7885711, Jun 13 2003 Medtronic, Inc Vagal stimulation for anti-embolic therapy
7890176, Jul 06 1998 Boston Scientific Neuromodulation Corporation Methods and systems for treating chronic pelvic pain
7890185, Aug 31 2001 Medtronic, Inc Treatment of disorders by unidirectional nerve stimulation
7904176, Sep 07 2006 Medtronic, Inc Techniques for reducing pain associated with nerve stimulation
7912555, Aug 31 2001 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
7930034, Jul 29 2005 Medtronic, Inc. Transmembrane sensing device for sensing bladder condition
7974693, Aug 31 2001 Medtronic, Inc Techniques for applying, configuring, and coordinating nerve fiber stimulation
8000805, Aug 31 2001 Medtronic, Inc. Implantable medical lead including tine markers
8036756, Aug 31 2001 Medtronics Inc Implantable medical electrical stimulation lead fixation method and apparatus
8060197, May 23 2003 Medtronic, Inc Parasympathetic stimulation for termination of non-sinus atrial tachycardia
8082039, Sep 08 2004 TC1 LLC Stimulation systems
8083663, Oct 06 1998 ASTORA WOMEN S HEALTH, LLC Pelvic disorder treatment
8160710, Jul 10 2006 Boston Scientific Corporation; Boston Scientific Scimed, Inc Systems and methods for implanting tissue stimulation electrodes in the pelvic region
8165692, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Implantable pulse generator power management
8180461, Nov 15 2000 Medtronics, Inc. Minimally invasive apparatus for implanting a sacral stimulation lead
8195296, Mar 03 2006 ASTORA WOMEN S HEALTH, LLC Apparatus for treating stress and urge incontinence
8195304, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Implantable systems and methods for acquisition and processing of electrical signals
8204591, May 23 2002 Medtronic, Inc Techniques for prevention of atrial fibrillation
8214048, Aug 18 2000 Boston Scientific Neuromodulation Corporation Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction
8229565, Sep 08 2004 TC1 LLC Methods for stimulating a dorsal root ganglion
8326438, Nov 15 2004 Medtronic, Inc Techniques for nerve stimulation
8340786, Oct 06 1998 ASTORA WOMEN S HEALTH, LLC Incontinence treatment device
8380312, Dec 31 2009 Boston Scientific Corporation; Boston Scientific Scimed, Inc Multi-zone stimulation implant system and method
8380318, Mar 24 2009 TC1 LLC Pain management with stimulation subthreshold to paresthesia
8386056, Aug 31 2001 Medtronic, Inc Parasympathetic stimulation for treating atrial arrhythmia and heart failure
8427953, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation and hashing
8467875, Feb 12 2004 MEDTRONIC URINARY SOLUTIONS, INC Stimulation of dorsal genital nerves to treat urologic dysfunctions
8494655, May 23 2002 Medtronic, Inc Electrode devices with resistive elements
8518092, Dec 06 2006 TC1 LLC Hard tissue anchors and delivery devices
8521292, Apr 24 2009 Medtronic, Inc Incontinence therapy objectification
8537682, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
8541232, Mar 08 2006 KWALATA TRADING LIMITED Composition comprising a progenitor/precursor cell population
8571651, Sep 07 2006 Medtronic, Inc Techniques for reducing pain associated with nerve stimulation
8571653, Aug 31 2001 Medtronic, Inc Nerve stimulation techniques
8588917, Aug 18 2000 Boston Scientific Neuromodulation Corporation Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction
8609082, Jan 25 2005 Medtronic, Inc Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
8626314, Aug 31 2001 Medtronic, Inc. Implantable medical lead including a plurality of tine elements
8649870, Feb 12 2004 MEDTRONIC URINARY SOLUTIONS, INC Systems and methods including lead and electrode structures sized and configured for implantation in adipose tissue
8685724, Jun 01 2004 KWALATA TRADING LIMITED In vitro techniques for use with stem cells
8706252, Jun 10 2004 Medtronic, Inc. Systems and methods for clinician control of stimulation system
8712546, Sep 08 2004 TC1 LLC Neurostimulation system
8725271, May 23 2002 Medtronic, Inc Electrode device with elongated electrode
8755893, Jun 08 2010 BLUEWIND MEDICAL LTD Tibial nerve stimulation
8761888, Jul 29 2005 Medtronic, Inc. Transmembrane sensing device for sensing bladder condition
8774942, Jul 10 2007 Boston Scientific Corporation; Boston Scientific Scimed, Inc Tissue anchor
8880192, Apr 02 2012 Medtronic, Inc Electrode cuffs
8909355, Nov 15 2004 Medtronic, Inc Techniques for nerve stimulation
8983624, Dec 06 2006 TC1 LLC Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
9044592, Jan 29 2007 TC1 LLC Sutureless lead retention features
9056197, Oct 27 2008 TC1 LLC Selective stimulation systems and signal parameters for medical conditions
9186504, Nov 15 2010 Rainbow Medical Ltd Sleep apnea treatment
9205255, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
9205259, Sep 08 2004 TC1 LLC Neurostimulation system
9205260, Sep 08 2004 TC1 LLC Methods for stimulating a dorsal root ganglion
9205261, Sep 08 2004 TC1 LLC Neurostimulation methods and systems
9216294, Jun 10 2004 Medtronic Urinary Solutions, Inc. Systems and methods for clinician control of stimulation systems
9220887, Jun 09 2011 Boston Scientific Corporation; Boston Scientific Scimed, Inc Electrode lead including a deployable tissue anchor
9234173, Mar 08 2006 Kwalata Trading Ltd. Regulating stem cells
9241778, Jan 11 2010 FORCONTI MEDICAL LTD Device and method for controlling fecal incontinence
9259569, May 15 2009 TC1 LLC Methods, systems and devices for neuromodulating spinal anatomy
9272140, Sep 06 2002 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
9308382, Jun 10 2004 MEDTRONIC URINARY SOLUTIONS, INC Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
9314618, Dec 06 2006 ST JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S A R L SJM LUX SMI Implantable flexible circuit leads and methods of use
9327110, Oct 27 2009 TC1 LLC Devices, systems and methods for the targeted treatment of movement disorders
9370660, Mar 29 2013 RAINBOW MEDICAL LTD. Independently-controlled bidirectional nerve stimulation
9409021, Oct 27 2008 TC1 LLC Selective stimulation systems and signal parameters for medical conditions
9427570, Dec 06 2006 TC1 LLC Expandable stimulation leads and methods of use
9427573, Jul 10 2007 ASTORA WOMEN S HEALTH, LLC Deployable electrode lead anchor
9433783, Apr 24 2009 Medtronic, Inc. Incontinence therapy
9446245, Mar 30 2001 Case Western Reserve University Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selectively physiological responses
9452287, Jan 21 2013 CALA HEALTH, INC Devices and methods for controlling tremor
9457186, Jul 31 2013 BLUEWIND MEDICAL LTD Bilateral feedback
9468762, Mar 24 2009 TC1 LLC Pain management with stimulation subthreshold to paresthesia
9480846, May 17 2006 MEDTRONIC URINARY SOLUTIONS, INC Systems and methods for patient control of stimulation systems
9486633, Sep 08 2004 TC1 LLC Selective stimulation to modulate the sympathetic nervous system
9539433, Mar 18 2009 Boston Scientific Corporation; Boston Scientific Scimed, Inc Electrode implantation in a pelvic floor muscular structure
9590899, May 26 2011 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
9597521, Jan 21 2015 BLUEWIND MEDICAL LTD. Transmitting coils for neurostimulation
9623233, Dec 06 2006 TC1 LLC Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
9649492, Dec 31 2014 Tsinghua University Variable frequency stimulation therapy method and implantable medical device
9713707, Nov 12 2015 BLUEWIND MEDICAL LTD Inhibition of implant migration
9724511, Apr 24 2009 Medtronic, Inc. Incontinence therapy
9724526, Jun 10 2004 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for operating the same
9731112, Sep 08 2011 Boston Scientific Corporation; Boston Scientific Scimed, Inc Implantable electrode assembly
9749228, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
9764146, Jan 21 2015 BLUEWIND MEDICAL LTD. Extracorporeal implant controllers
9782583, Feb 21 2012 System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
9782589, Jun 10 2015 BLUEWIND MEDICAL LTD Implantable electrostimulator for improving blood flow
9802041, Jun 02 2014 CALA HEALTH, INC Systems for peripheral nerve stimulation to treat tremor
9861812, Dec 06 2012 BLUE WIND MEDICAL LTD Delivery of implantable neurostimulators
9889298, Mar 03 2006 ASTORA WOMEN S HEALTH, LLC Electrode sling for treating stress and urge incontinence
9950160, Feb 21 2012 System and method for electrical stimulation of anorectal structures to treat anal dysfunction
9967180, May 06 2005 CORRIGENT CORPORATION Tunnel provisioning with link aggregation
Patent Priority Assignee Title
3650276,
3667477,
4569351, Dec 20 1984 HERMAN M FINCH UNIVERSITY OF HEALTH SCIENCES THE CHICAGO MEDICAL SCHOOL Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 22 1986The Regents of the University of California(assignment on the face of the patent)
Aug 14 1991University of CaliforniaNATIONAL INSTITUTES OF HEALTH NIH , U S DEPT OF HEALTH AND HUMAN SERVICES DHHS , U S GOVERNMENTCONFIRMATORY LICENSE SEE DOCUMENT FOR DETAILS 0220400613 pdf
Date Maintenance Fee Events
Aug 08 1991ASPN: Payor Number Assigned.
Oct 01 1991M173: Payment of Maintenance Fee, 4th Year, PL 97-247.
Dec 03 1991LSM3: Pat Hldr no Longer Claims Small Ent Stat as Nonprofit Org.
Sep 29 1995M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Oct 25 1999M185: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Apr 26 19914 years fee payment window open
Oct 26 19916 months grace period start (w surcharge)
Apr 26 1992patent expiry (for year 4)
Apr 26 19942 years to revive unintentionally abandoned end. (for year 4)
Apr 26 19958 years fee payment window open
Oct 26 19956 months grace period start (w surcharge)
Apr 26 1996patent expiry (for year 8)
Apr 26 19982 years to revive unintentionally abandoned end. (for year 8)
Apr 26 199912 years fee payment window open
Oct 26 19996 months grace period start (w surcharge)
Apr 26 2000patent expiry (for year 12)
Apr 26 20022 years to revive unintentionally abandoned end. (for year 12)